Patrick A. Roth
Impact in
Papers in
- Co-authors
- Michael Weller (135 shared papers)David A. Reardon (7 shared papers)Guido Reifenberger (18 shared papers)W Wick (15 shared papers)Caroline Happold (15 shared papers)Manuela Silginer (20 shared papers)Matthias Preusser (11 shared papers)Tobias Weiß (14 shared papers)
- Journals
- Neuro-Oncology (23 papers)Journal of Neuro-Oncology (7 papers)Clinical Cancer Research (6 papers)Oncotarget (5 papers)Current Opinion in Neurology (5 papers)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Patrick A. Roth
179 papers receiving 7.5k citations
Patrick A. Roth's Hit Papers
Peers
Comparison fields: 5 of 134
- Genetics 2.9k
- Neurology 1.2k
- Cancer Research 925
- Oncology 1.7k
- Immunology 1.3k
Countries citing papers authored by Patrick A. Roth
This map shows the geographic impact of Patrick A. Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick A. Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick A. Roth more than expected).
Fields of papers citing papers by Patrick A. Roth
This network shows the impact of papers produced by Patrick A. Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick A. Roth. The network helps show where Patrick A. Roth may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick A. Roth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 192 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma Hit paper breakdown → | 2020 | 1041 |
| 2 | Molecular targeted therapy of glioblastoma Hit paper breakdown → | 2019 | 516 |
| 3 | 1999 | 304 | |
| 4 | 2010 | 255 | |
| 5 | 2017 | 249 | |
| 6 | 2012 | 183 | |
| 7 | 2017 | 182 | |
| 8 | 2011 | 180 | |
| 9 | 2016 | 162 | |
| 10 | 2010 | 145 | |
| 11 | 2017 | 133 | |
| 12 | 2009 | 124 | |
| 13 | 2012 | 119 | |
| 14 | 2020 | 105 | |
| 15 | 2017 | 98 | |
| 16 | 2013 | 94 | |
| 17 | 2013 | 93 | |
| 18 | 2007 | 89 | |
| 19 | 2015 | 89 | |
| 20 | 1991 | 86 |
About Patrick A. Roth
Patrick A. Roth is a scholar working on Genetics, Neurology, Oncology, Immunology and Pathology and Forensic Medicine, having authored 192 papers that have together received 7.7k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (75 papers), CNS Lymphoma Diagnosis and Treatment (19 papers), Brain Metastases and Treatment (18 papers), Immunotherapy and Immune Responses (13 papers), Immune cells in cancer (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), CAR-T cell therapy research (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). The work is most often cited by research in Genetics (2.9k citations), Neurology (1.2k citations), Cancer Research (925 citations), Oncology (1.7k citations) and Immunology (1.3k citations). Patrick A. Roth has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Michael Weller, David A. Reardon, Guido Reifenberger, W Wick, Caroline Happold, Manuela Silginer, Matthias Preusser, Tobias Weiß, E. Le Rhun and Martin J. van den Bent. Their work appears in journals such as Neuro-Oncology, Journal of Neuro-Oncology, Clinical Cancer Research, Oncotarget and Current Opinion in Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.